HK Stock MarketDetailed Quotes

CONSUN PHARMA (01681)

Watchlist
  • 14.500
  • -0.490-3.27%
Market Closed May 18 16:47 CST
12.20BMarket Cap10.23P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CONSUN PHARMA (01681) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
15.17%3.42B
23.65%1.57B
14.56%2.97B
13.30%1.27B
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
Operating income
15.17%3.42B
23.65%1.57B
14.56%2.97B
13.30%1.27B
10.71%2.59B
12.70%1.12B
14.43%2.34B
12.07%993.53M
16.65%2.04B
15.76%886.53M
Cost of sales
-3.46%-750.24M
-12.11%-359.91M
-8.48%-725.13M
-13.33%-321.03M
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
Operating expenses
-3.46%-750.24M
-12.11%-359.91M
-8.48%-725.13M
-13.33%-321.03M
-15.90%-668.44M
-10.89%-283.26M
-11.48%-576.74M
-13.38%-255.44M
-19.98%-517.32M
-15.97%-225.29M
Gross profit
18.96%2.67B
27.56%1.21B
16.67%2.24B
13.28%947.52M
9.01%1.92B
13.32%836.42M
15.42%1.76B
11.62%738.09M
15.56%1.53B
15.68%661.24M
Selling expenses
-9.29%-1.07B
-25.18%-515.65M
-15.18%-981.58M
-13.78%-411.91M
-10.40%-852.21M
-10.57%-362.03M
-24.50%-771.96M
-18.28%-327.42M
-14.20%-620.04M
-23.55%-276.81M
Administrative expenses
-42.89%-445.63M
-31.82%-177.57M
1.18%-311.87M
1.49%-134.71M
2.14%-315.6M
-1.07%-136.74M
-15.20%-322.5M
-31.87%-135.3M
-37.86%-279.96M
-16.87%-102.6M
Impairment and provision
-88.43%1.02M
-106.62%-607K
-30.31%8.78M
-47.69%9.17M
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
-Other impairment is provision
-88.43%1.02M
-106.62%-607K
-30.31%8.78M
-47.69%9.17M
-61.23%12.6M
37.08%17.53M
80.09%32.49M
850.22%12.79M
161.45%18.04M
109.28%1.35M
Special items of operating profit
-39.92%52.65M
-36.62%23.62M
-26.05%87.63M
25.74%37.26M
110.16%118.5M
16.44%29.63M
-11.04%56.39M
-14.47%25.45M
7.75%63.38M
144.70%29.76M
Operating profit
15.05%1.2B
20.37%538.47M
18.09%1.05B
16.25%447.33M
16.85%884.97M
22.70%384.81M
6.85%757.33M
0.22%313.61M
17.12%708.77M
21.57%312.93M
Financing cost
82.48%-4.36M
81.55%-2.47M
-17.04%-24.89M
-85.58%-13.38M
-94.49%-21.26M
-76.04%-7.21M
15.28%-10.93M
21.89%-4.09M
39.70%-12.91M
54.40%-5.24M
Share of profits of associates
-2,319.70%-1.6M
---763K
---66K
----
----
----
----
----
----
----
Earning before tax
17.28%1.2B
23.34%535.24M
18.11%1.02B
14.92%433.96M
15.72%863.7M
22.00%377.61M
7.26%746.39M
0.59%309.52M
19.21%695.86M
25.12%307.69M
Tax
-4.44%-107.29M
1.85%-32.39M
-33.16%-102.73M
-10.82%-33M
-23.05%-77.15M
-114.56%-29.78M
42.35%-62.7M
77.90%-13.88M
-6.62%-108.74M
-28.91%-62.79M
After-tax profit from continuing operations
18.72%1.09B
25.41%502.85M
16.63%917.37M
15.27%400.96M
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
Earning after tax
18.72%1.09B
25.41%502.85M
16.63%917.37M
15.27%400.96M
15.04%786.55M
17.65%347.83M
16.45%683.7M
20.72%295.64M
21.87%587.12M
24.18%244.91M
Minority profit
59.99%11.07M
280.75%4.55M
242.38%6.92M
1,967.19%1.2M
155.70%2.02M
94.12%-64K
125.86%790K
81.02%-1.09M
82.08%-3.06M
50.84%-5.74M
Profit attributable to shareholders
18.41%1.08B
24.65%498.3M
16.05%910.46M
14.91%399.77M
14.88%784.53M
17.24%347.89M
15.71%682.91M
18.39%296.73M
18.32%590.17M
19.99%250.64M
Basic earnings per share
14.41%1.27
18.00%0.59
12.12%1.11
13.43%0.5
15.12%0.99
17.77%0.4408
16.22%0.86
19.51%0.3743
21.31%0.74
23.94%0.3132
Diluted earnings per share
15.60%1.26
18.37%0.58
11.22%1.09
12.21%0.49
13.95%0.98
16.98%0.4367
17.81%0.86
19.76%0.3733
19.67%0.73
23.35%0.3117
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 15.17%3.42B23.65%1.57B14.56%2.97B13.30%1.27B10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M
Operating income 15.17%3.42B23.65%1.57B14.56%2.97B13.30%1.27B10.71%2.59B12.70%1.12B14.43%2.34B12.07%993.53M16.65%2.04B15.76%886.53M
Cost of sales -3.46%-750.24M-12.11%-359.91M-8.48%-725.13M-13.33%-321.03M-15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M
Operating expenses -3.46%-750.24M-12.11%-359.91M-8.48%-725.13M-13.33%-321.03M-15.90%-668.44M-10.89%-283.26M-11.48%-576.74M-13.38%-255.44M-19.98%-517.32M-15.97%-225.29M
Gross profit 18.96%2.67B27.56%1.21B16.67%2.24B13.28%947.52M9.01%1.92B13.32%836.42M15.42%1.76B11.62%738.09M15.56%1.53B15.68%661.24M
Selling expenses -9.29%-1.07B-25.18%-515.65M-15.18%-981.58M-13.78%-411.91M-10.40%-852.21M-10.57%-362.03M-24.50%-771.96M-18.28%-327.42M-14.20%-620.04M-23.55%-276.81M
Administrative expenses -42.89%-445.63M-31.82%-177.57M1.18%-311.87M1.49%-134.71M2.14%-315.6M-1.07%-136.74M-15.20%-322.5M-31.87%-135.3M-37.86%-279.96M-16.87%-102.6M
Impairment and provision -88.43%1.02M-106.62%-607K-30.31%8.78M-47.69%9.17M-61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M
-Other impairment is provision -88.43%1.02M-106.62%-607K-30.31%8.78M-47.69%9.17M-61.23%12.6M37.08%17.53M80.09%32.49M850.22%12.79M161.45%18.04M109.28%1.35M
Special items of operating profit -39.92%52.65M-36.62%23.62M-26.05%87.63M25.74%37.26M110.16%118.5M16.44%29.63M-11.04%56.39M-14.47%25.45M7.75%63.38M144.70%29.76M
Operating profit 15.05%1.2B20.37%538.47M18.09%1.05B16.25%447.33M16.85%884.97M22.70%384.81M6.85%757.33M0.22%313.61M17.12%708.77M21.57%312.93M
Financing cost 82.48%-4.36M81.55%-2.47M-17.04%-24.89M-85.58%-13.38M-94.49%-21.26M-76.04%-7.21M15.28%-10.93M21.89%-4.09M39.70%-12.91M54.40%-5.24M
Share of profits of associates -2,319.70%-1.6M---763K---66K----------------------------
Earning before tax 17.28%1.2B23.34%535.24M18.11%1.02B14.92%433.96M15.72%863.7M22.00%377.61M7.26%746.39M0.59%309.52M19.21%695.86M25.12%307.69M
Tax -4.44%-107.29M1.85%-32.39M-33.16%-102.73M-10.82%-33M-23.05%-77.15M-114.56%-29.78M42.35%-62.7M77.90%-13.88M-6.62%-108.74M-28.91%-62.79M
After-tax profit from continuing operations 18.72%1.09B25.41%502.85M16.63%917.37M15.27%400.96M15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M
Earning after tax 18.72%1.09B25.41%502.85M16.63%917.37M15.27%400.96M15.04%786.55M17.65%347.83M16.45%683.7M20.72%295.64M21.87%587.12M24.18%244.91M
Minority profit 59.99%11.07M280.75%4.55M242.38%6.92M1,967.19%1.2M155.70%2.02M94.12%-64K125.86%790K81.02%-1.09M82.08%-3.06M50.84%-5.74M
Profit attributable to shareholders 18.41%1.08B24.65%498.3M16.05%910.46M14.91%399.77M14.88%784.53M17.24%347.89M15.71%682.91M18.39%296.73M18.32%590.17M19.99%250.64M
Basic earnings per share 14.41%1.2718.00%0.5912.12%1.1113.43%0.515.12%0.9917.77%0.440816.22%0.8619.51%0.374321.31%0.7423.94%0.3132
Diluted earnings per share 15.60%1.2618.37%0.5811.22%1.0912.21%0.4913.95%0.9816.98%0.436717.81%0.8619.76%0.373319.67%0.7323.35%0.3117
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----KPMG--KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.81%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.82%
4
SINOPEC CORP
00386
-1.54%
5
SHANGHAI PECHEM
00338
-2.36%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +36.67%
Sample Name
Sample Code
 +29.14%
Sample Name
Sample Code
 +25.72%
4
Digital China Group
000034
+19.11%
5
Business-intelligence Of Oriental Nations Corporation
300166
+17.75%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -